Table 2.
Isolate |
MICs in monotherapy (μg/mL) |
MICs in combination (μg/mL) |
FICIs | ||
---|---|---|---|---|---|
CCM | EGCG | CCM | EGCG | ||
AB 19606 |
>256 |
1024 |
4 |
256 |
0.258 (S) |
AB 14 |
>256 |
1024 |
4 |
512 |
0.508 (Ad) |
AB 16 |
>256 |
1024 |
32 |
512 |
0.56 (Ad) |
AB 186 |
>256 |
512 |
64 |
128 |
0.38 (S) |
AB 202 |
>256 |
1024 |
64 |
512 |
0.63 (Ad) |
AB 205 |
>256 |
1024 |
4 |
512 |
0.508 (Ad) |
AB 292 |
>256 |
1024 |
4 |
256 |
0.258 (S) |
AB 306 |
>256 |
128 |
4 |
32 |
0.258 (S) |
AB 308 | >256 | 256 | 4 | 64 | 0.258 (S) |
MICs were within +/-1 dilution on replicate tests. CCM = curcumin, EGCG = epigallocatechin gallate, S = synergy, Ad = additive effect.